Patents by Inventor Silvia Albert

Silvia Albert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense oligonucleotides for the treatment of Stargardt disease
    Publication number: 20220204972
    Abstract: The present invention relates to the field of medicine. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Stargardt disease.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 30, 2022
    Applicant: Stichting Katholieke Universiteit
    Inventors: Robert Wilhelmus Johanna Collin, Alejandro Garanto Iglesias, Franciscus Peter Maria Cremers, Silvia Albert
  • Antisense oligonucleotides for the treatment of Stargardt disease
    Patent number: 11236333
    Abstract: The present invention relates to the field of medicine. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Stargardt disease.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: February 1, 2022
    Assignee: STICHTING KATHOLIEKE UNIVERSITEIT
    Inventors: Robert Wilhelmus Johanna Collin, Alejandro Garanto Iglesias, Franciscus Peter Maria Cremers, Silvia Albert
  • ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF STARGARDT DISEASE
    Publication number: 20190367919
    Abstract: The present invention relates to the field of medicine. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Stargardt disease.
    Type: Application
    Filed: December 13, 2017
    Publication date: December 5, 2019
    Applicant: STICHTING KATHOLIEKE UNIVERSITEIT
    Inventors: Robert Wilhelmus Johanna Collin, Alejandro Garanto Iglesias, Franciscus Peter Maria Cremers, Silvia Albert